| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |